| Oleg Sergeevich Kouskov, MD | |
|
2347 E Gala St, Meridian, ID 83642-4881 | |
| (208) 323-3767 | |
| Not Available |
| Full Name | Oleg Sergeevich Kouskov |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 2347 E Gala St, Meridian, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053521203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | M11223 (Idaho) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | M11223 (Idaho) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| St Luke's Wood River Medical Center | Ketchum, ID | Hospital |
| St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.
Members of the House Energy and Commerce Health Subcommittee on Tuesday voted to approve legislation that would repeal the Community Living Assistance Services and Supports Act included in the healthcare reform law. The Patient Protection and Affordable Care Act tasked HHS with developing a benefit plan for CLASS, a voluntary long-term-care insurance program, that was financially sustainable and also met the legal requirements of the statute.
Life Technologies Corporation, today announced that just six weeks following the launch of the Ion Torrent PGM sequencer, independent researchers will present data they generated with the system at the annual Advances in Genome Biology and Technology (AGBT) conference.
The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.
› Verified 3 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.
Members of the House Energy and Commerce Health Subcommittee on Tuesday voted to approve legislation that would repeal the Community Living Assistance Services and Supports Act included in the healthcare reform law. The Patient Protection and Affordable Care Act tasked HHS with developing a benefit plan for CLASS, a voluntary long-term-care insurance program, that was financially sustainable and also met the legal requirements of the statute.
Life Technologies Corporation, today announced that just six weeks following the launch of the Ion Torrent PGM sequencer, independent researchers will present data they generated with the system at the annual Advances in Genome Biology and Technology (AGBT) conference.
The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oleg Sergeevich Kouskov, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 | Oleg Sergeevich Kouskov, MD 2347 E Gala St, Meridian, ID 83642-4881 Ph: (208) 323-3767 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.
Members of the House Energy and Commerce Health Subcommittee on Tuesday voted to approve legislation that would repeal the Community Living Assistance Services and Supports Act included in the healthcare reform law. The Patient Protection and Affordable Care Act tasked HHS with developing a benefit plan for CLASS, a voluntary long-term-care insurance program, that was financially sustainable and also met the legal requirements of the statute.
Life Technologies Corporation, today announced that just six weeks following the launch of the Ion Torrent PGM sequencer, independent researchers will present data they generated with the system at the annual Advances in Genome Biology and Technology (AGBT) conference.
The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-experienced adults who are experiencing virologic failure with HIV-1 strains resistant to an NNRTI and other antiretroviral (ARV) agents.
› Verified 3 days ago
Mr. Eric Ld Scholten, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2347 E Gala St, Meridian, ID 83642 Phone: 208-323-3767 Fax: 208-323-3768 | |
Lynn Ge-zerbe, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1759 S Millenium Way, Meridian, ID 83642 Phone: 208-387-6546 Fax: 888-334-8747 | |
Dr. Aaron Dunham, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3025 W Cherry Lane, Ste 204, Meridian, ID 83642 Phone: 208-302-3300 Fax: 208-302-3355 | |
John T Witte, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2235 E Gala St, Meridian, ID 83642 Phone: 208-887-3724 Fax: 208-887-3724 | |
John B Dever, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 875 S Vanguard Way Ste 310, Meridian, ID 83642 Phone: 208-463-3000 | |
Dr. Wendi M Norris, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2347 E Gala St, Meridian, ID 83642 Phone: 208-323-0031 Fax: 208-323-0064 |